A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

• Status: Completed
• Trial end date: 2006-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Alcon Research
• Treatments: Travoprost

Criteria

Inclusion Criteria:

• Adult patients of either sex of any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component) or ocular hypertension.

• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Under age 18.

• Other protocol-defined exclusion criteria may apply.